Pharmaceutical Management Agency
A public authority, also called PHARMAC
45 requests
3 followers
- all requests
- successful requests
- unsuccessful requests
- unresolved requests
Why have you restricted Ivermectin?
Follow up sent to Pharmaceutical Management Agency by Annie Weston on .
Awaiting classification.
Thank you for your quick reply.
However I did not ask why you are not funding Ivermectin.
I asked why you have restricted its use for the preven...
Correspondence between Pharmac and NZMS
Response by Pharmaceutical Management Agency to D Smith on .
Awaiting classification.
Kia ora D Smith
Please find attached an extension letter for your recent OIA request.
Please feel free to contact us if you have any questi...
Estimating the number of people prescribed PrEP
Response by Pharmaceutical Management Agency to Bianca Sepulveda on .
Awaiting classification.
Kia ora Bianca
Please find attached a response to your recent request for information.
Ngā mihi
Melody Willis ([1]she/her) | Gove...
Information regarding Dexcom CGMS and Libre FGMS
Response by Pharmaceutical Management Agency to D Smith on .
Awaiting classification.
Kia ora D Smith
Further to our previous email to you on Friday 19 March 2021, please find
attached the final response to your request for inform...
Cost of PreP since funding began in 2018
Response by Pharmaceutical Management Agency to Elliot Ikilei on .
Successful.
Kia ora Elliot
Please find attached a response to your request for information received
by PHARMAC on 6 January 2021.
Please feel free to...
Cost of funding Tramadol in 2019
Response by Pharmaceutical Management Agency to Brianna Stewart on .
Successful.
Kia ora Brianna
Please find the response to your OIA 2020-21-020 dated 18 August 2020
regarding tramadol funding for calendar year 2019.
N...
PTAC subcommittees- OIA request
Response by Pharmaceutical Management Agency to john luke on .
Successful.
Kia ora John
Please find attached to this email a response to your OIA request
2020-21-015 dated 14 July 2020.
Ngā mihi
Melody W...
Discontinuation of Phenelzine Sulphare
Response by Pharmaceutical Management Agency to Megs on .
Successful.
Dear Megs
Attached is PHARMAC's response to your recent information request.
Kind regards
PHARMAC | Te Pātaka Whaioranga | PO Box 10 254 | Level 9,...
Rationale for defunding of Androderm 2.5mg Patches
Response by Pharmaceutical Management Agency to Scout Barbour-Evans on .
Successful.
Hello Scout
Androderm 2.5mg patches were delisted from the Pharmaceutical Schedule from 1 March 2018.
In October 2016, the manufacturers proposed del...
Consumer Advisory Committee (CAC)
Response by Pharmaceutical Management Agency to john luke on .
Successful.
Good afternoon John
Please find attached PHARMAC's response to your recent request for information about CAC membership.
Kind regards, Susan
Susan...
Shortage of Phenelzine sulphate
Response by Pharmaceutical Management Agency to Megs on .
Successful.
Dear Megs
Please find attached a letter and related documents related to your request for information about phenelzine supply.
Kind regards
Simon E...
Supporting/supplementary documentation to the 1 & 2 November 2018 PTAC minutes on funding of Whole Thyroid Extract and Liothyronine
Response by Pharmaceutical Management Agency to Belinda Hodson on .
Awaiting classification.
Good morning Belinda
Please find attached PHARMAC's response to your recent request for information about the funding of Whole Thyroid Extract and Lio...
Citation list for PHARMAC funded thyroid medications and patient survey data
Response by Pharmaceutical Management Agency to Belinda Hodson on .
Partially successful.
Dear Belinda
Please find attached further correspondence in relation to your request for information about thyroid medications (OIA reference 2019-20-...
Approval of PHARMAC funded thyroid medications
Response by Pharmaceutical Management Agency to Belinda Hodson on .
Partially successful.
Good afternoon Belinda.
Please find attached our response to your request for PTAC minutes and the Endocrinology Subcommittee minutes that recommended...
PrEP Correspondence
Response by Pharmaceutical Management Agency to Gemma Crawley on .
Information not held.
Dear Gemma
Please find attached a response to your request for information about PREP
correspondence
Kind regards
Simon England | Se...
Pharmac Funding Applications
Response by Pharmaceutical Management Agency to Gemma Crawley on .
Successful.
Hi Gemma
Most of the funding applications we receive come from suppliers.
NZAF did apply to us for PrEP.
And the Breast Cancer Aotearoa Coalition appl...
Hi Gemma apologies the wrong link, Vikki
https://www.pharmac.govt.nz/news/notification-2018-02-07-prep/
Vanlafaxine - Bioavailability studies
Response by Pharmaceutical Management Agency to R Whyte on .
Awaiting classification.
Dear Mt Whyte
Please find attached a response to you and the information requested.
Kind regards
Donna Jennings
PHARMAC
10 Jun...
Consumer Advisory Committee
Response by Pharmaceutical Management Agency to john luke on .
Successful.
Hello John
I am replying on behalf of Katie.
The member's term of appointment is for up to three years.
You can express an interest by contacting [e...
People using PrEP contracting HIV
Response by Pharmaceutical Management Agency to The Magic Roast on .
Awaiting classification.
Hi Jacky, huge apologies! Here is our response.
Have a lovely weekend
Jane
Jacky Thorndon
[FOI #9905 email]
26 April 2019
Dear Jacky,
REQUEST FOR I...
List of most most costly and most prescribed medications
Response by Pharmaceutical Management Agency to Sam Wagener on .
Refused.
Dear Mr Wagener
Please find attached a letter regarding your request for official
information.
Yours sincerely
Ministerial Support Services
[em...
Cost of funding PrEP
Response by Pharmaceutical Management Agency to Felix Swadel on .
Awaiting classification.
Hi Felix
Please see attached the response to your OIA request.
Kind regards
Dean
PHARMAC
1 November 2018
Felix Swadel
Via email:...
Arrow Venlafaxine needs to come back under NZ funding.
Response by Pharmaceutical Management Agency to VICKI CAREY on .
Partially successful.
Kia ora Vicki
Thank you for your enquiry. You have asked why the Arrow-Venlafaxine XR
and Efexor XR brands were removed when it was doing good f...
Dear Trudi
Thank you for your query regarding the initial listing date for
Arrow-Venlafaxine XR tablets in the Pharmaceutical Schedule.
Ar...
Who did the research that was used to compare Enlafax with other brands?
Response by Pharmaceutical Management Agency to Trudi Webber on .
Successful.
Dear Ms Webber,
Kindly note the Ministry is awaiting your clarification please on your
request.
Kind regards
Maima
Ministerial Services (OIA)
[...
Only requests made using FYI are shown. ?
More about this authority
Home page of authorityView email address
Ask us to update Official Information email
